ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant, Medical

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,112Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 251

$447K Total Retail Price of All Prescriptions

Rank: 5 out of 251

681 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 681 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

16% of this provider’s 681 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 5,973 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 7.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
SIMVASTATIN 423 319 1 3
HYDROCODONE-ACETAMINOPHEN 368 215 S3 2 7
LISINOPRIL 365 273 3 1
LEVOTHYROXINE SODIUM 313 235 4 2
OMEPRAZOLE 256 187 5 5
FUROSEMIDE 229 158 6 11
METFORMIN HCL 221 166 7 4
AMLODIPINE BESYLATE 189 157 8 6
CARISOPRODOL 171 34 R 9 30
OXYCODONE HCL 169 56 S2 10 16
ATENOLOL 160 126 11 14
METOPROLOL TARTRATE 158 140 12 10
PRAVASTATIN SODIUM 153 122 13 23
GABAPENTIN 143 87 14 8
IBUPROFEN 132 71 15 33
TRAMADOL HCL 122 87 16 12
POTASSIUM CHLORIDE 107 78 17 31
ZOLPIDEM TARTRATE 105 60 18 22
GLIPIZIDE 104 74 19 54
HYDROCHLOROTHIAZIDE 97 93 20 9
RANITIDINE HCL 93 70 21 13
LOVASTATIN 91 86 22 15
SERTRALINE HCL 90 73 23 49
CARVEDILOL 85 49 24 34
FLUTICASONE PROPIONATE 78 59 25 26
MELOXICAM 76 70 26 70
FINASTERIDE 74 74 27 41
TERAZOSIN HCL 72 72 28 56
OXYBUTYNIN CHLORIDE 71 57 29 74
FLUOXETINE HCL 71 20 29 81
TAMSULOSIN HCL 70 60 31 20
CIPROFLOXACIN HCL 68 45 32 35
VENTOLIN HFA 65 32 33 177
AMLODIPINE BESYLATE-BENAZEPRIL 65 52 33 177
ALENDRONATE SODIUM 64 46 35 24
PREDNISONE 61 53 36 36
LOSARTAN POTASSIUM 61 56 36 32
AMITRIPTYLINE HCL 59 34 R 38 47
METOPROLOL SUCCINATE 58 43 39 28
GEMFIBROZIL 57 44 40 75
NAPROXEN 57 43 40 69
ADVAIR DISKUS 54 31 42 45
WARFARIN SODIUM 54 41 42 19
MORPHINE SULFATE ER 53 26 S2 44 25
SPIRIVA 52 43 45 51
ALLOPURINOL 52 47 45 91
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 48 47 42
GLIMEPIRIDE 51 39 47 104
PROAIR HFA 50 25 49 17
CLOPIDOGREL 50 45 49 39
PLAVIX 50 44 49 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 17, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.